HBOT reduced a future dementia marker of mine by 28%.

Details:
+ pTAU217 just got FDA-cleared for early Alzheimer’s screening. It also has prognostic value for healthy brains.

+ The FDA just approved approved pTAU217/A𝛃42 ratio as the first blood test for the early…